Navigation Links
NCPA Responds to Consumer Groups' Request for CVS Caremark Divestiture
Date:4/15/2011

ALEXANDRIA, Va., April 15, 2011 /PRNewswire-USNewswire/ -- The New York Times reports today that the Federal Trade Commission (FTC) has received a letter from the Consumer Federation of America, Community Catalyst, Consumer Union, National Legislative Association on Prescription Drug Prices and U.S. PIRG asking for divestiture of CVS Caremark. In response, National Community Pharmacists Association (NCPA) Executive Vice President and CEO Douglas Hoey, RPh, MBA, issued the following statement:

(Logo: http://photos.prnewswire.com/prnh/20100106/DC33253LOGO)

"When the FTC prepared to approve the CVS Caremark merger, NCPA and others warned that the merger would lead to Caremark sharing non-CVS patient data with CVS in order to increase its market share.  Unsurprisingly, after the 2007 merger, evidence mounted of anti-competitive and anti-privacy business practices through programs such as the ironically named 'Maintenance Choice.'  In late 2008, NCPA argued that the best recourse was to urge an FTC investigation of CVS Caremark's alleged improprieties, which would hopefully lead to corrective action. Other observers, including Members of Congress from both parties and consumer groups, agreed. The investigation began in the latter part of 2009, but the FTC has yet to weigh in with its findings.

"Now, several national, respected consumer groups are seeking the most comprehensive solution – CVS Caremark's divestiture – to the
'/>"/>

SOURCE National Community Pharmacists Association
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Solvay Pharmaceuticals, Inc. Responds to Advisory Committee Recommendation for Further Study of Tedisamil to Treat Atrial Fibrillation
2. Roche responds to announcement of IDEAL hepatitis C trial results
3. GlaxoSmithKline Responds to FDA on CERVARIX(R) and Plans to Submit Final Study Data for Approval
4. GSK Believes There Is No Liver Safety Issue With AVANDIA; Responds to Public Citizen Petition
5. AstraZeneca Responds to FDA Joint Advisory Committees Recommendation on SYMBICORT(R)
6. EPSScentral Responds to Pandemic Alert
7. Endologix Responds to Alleged Patent Infringement
8. U.S. Kidney Dialysis Community Responds to Haitis Emergency Plea for Life-Saving Dialysis Care
9. Fenwal Responds to New Lawsuit From Haemonetics; Reiterates Commitment to Blood Centers
10. Philips Responds to Industry Concerns With Focus on Radiation Dose Management Products Designed for Clinicians and Patients
11. GlaxoSmithKline Responds to US Senate Committee on Finance Report on Avandia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... than a third of reproductive-aged women enrolled in Medicaid, and ... a prescription for an opioid pain medication each year during ... Mortality Weekly Report (MMWR). Opioids are typically ... pain.  They are also found in some prescription cough medications. ...
(Date:1/23/2015)... Jan. 23, 2015  HyGreen, Inc., a leader in hand ... with RCA Medical, a subsidiary of Ascendis Health Limited, ... Each year, hundreds of millions of patients around ... organisms are transmitted from patient to patient via the ...
(Date:1/23/2015)... 23, 2015 Cord Blood America, Inc. ( www.cordblood-america.com ) ... "Company")  filed a Preliminary Proxy Statement, Schedule 14A, with the ... provides an update for shareholders detailing why a "YES" vote ... Dear Shareholders, As we reflect upon the ...
Breaking Medicine Technology:Opioid painkillers widely prescribed among reproductive age women 2Opioid painkillers widely prescribed among reproductive age women 3HyGreen Partners with RCA Medical in Johannesburg, South Africa 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 3Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 4
(Date:1/22/2015)... NY (PRWEB) January 22, 2015 ... of Sports Medicine flagship journal Medicine & Science ... L-Citrulline before exercise may help reduce gastrointestinal (GI) ... 1 , Participants in the double-blind, placebo-controlled ...
(Date:1/22/2015)... Florida (PRWEB) January 22, 2015 IsoComforter, Inc. ... therapy machine with patented IsoTube design to treat specific body ... introduced the most progressive and easy to use patented cold ... post-operative and sports related orthopedic and muscle injuries. IsoComforter ...
(Date:1/22/2015)... Mass. (PRWEB) January 22, 2015 EBSCO ... (AMA) are expanding their relationship in an effort to ... around the world. While EBSCO has long made AMA journals ... a sales agent for The JAMA Network. , ...
(Date:1/22/2015)... Compare-autoinsurance.org has released a new blog post presenting a ... insurance policy . , Some types of vehicles cannot be ... newly released blog post to see if their vehicle qualifies for ... are some of the cars that cannot be covered by a ...
(Date:1/22/2015)... State Forestry Institute of Mecklenburg-Vorpommern in Germany ... from GEOSYSTEMS, a dedicated Hexagon Geospatial and Intergraph partner ... Geospatial’s ERDAS APOLLO for cataloging, managing, and ... clouds and documents. This effort will enable the State ...
Breaking Medicine News(10 mins):Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:IsoComforter Introduces Best of Class Cold Therapy Product to the Worldwide Market 2Health News:EBSCO Expands Partnership with the American Medical Association 2Health News:EBSCO Expands Partnership with the American Medical Association 3Health News:EBSCO Expands Partnership with the American Medical Association 4Health News:Some Vehicles Cannot Be Covered By An Auto Insurance Policy! 2Health News:State Forestry Institute Mecklenburg-Vorpommern, Germany Embraces Hexagon Geospatial Technology 2Health News:State Forestry Institute Mecklenburg-Vorpommern, Germany Embraces Hexagon Geospatial Technology 3
... today announced an agreement with two non-profit organizations ... for rare blood cancers. The cooperative research ... shared commitment to move therapies for rare blood ... treatments can eventually be commercialized. The agreement is ...
... researchers have faced a baffling riddle: how to unravel a disorder ... brain. Now a UCLA study is the ... molecular level, resulting in an autistic brain that differs dramatically in ... online edition of Nature , the findings provide new insight ...
... News) -- A new drug that had shown promise in ... second stoke in someone who,s already had one, a new ... early because the drug, terutroban, showed no extra benefit. ... as effective as aspirin at preventing blood clots, and scientists ...
... Nationwide Children,s have received a grant from the National ... for MPS IIIB that has been shown effective in ... Mucopolysaccharidosis (MPS) IIIB, also known as Sanfilippo Syndrome B, ... the essential enzyme NAGLU. Children with MPS IIIB appear ...
... K. Babayan, MD, chief of the Department of Urology ... the Department of Urology at Boston University School of ... at their annual meeting in Washington, DC, last week ... specialty of urology and the AUA. Babayan received ...
... drink-drivers are more likely to be older, better-educated and ... study by academics at The University of Nottingham found ... triggers in alcohol-related offences committed by women. And ... to face the consequences of their crime can intensify ...
Cached Medicine News:Health News:NIH and non-profits sign research and development agreement 2Health News:Autism changes molecular structure of the brain, UCLA study finds 2Health News:Autism changes molecular structure of the brain, UCLA study finds 3Health News:Study Finds Aspirin Still Best at Preventing 2nd Stroke 2Health News:NIH grant for the move toward clinical trials targeting the lysosomal storage disease MPSIIIB 2Health News:Research study reveals profile for female drunk-drivers 2Health News:Research study reveals profile for female drunk-drivers 3
ICL manipulator, blunt, forked tip...
ICL manipulator with textured hemi-ball tip...
ICL manipulator with textured micro-ball tip....
0.25 mm diameter textured tip with protective guard....
Medicine Products: